We are live on
!
Find out more
Krystal Biotech
KRYS
KRYS
334 hedge funds and large institutions have $7.02B invested in Krystal Biotech in 2025 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 112 increasing their positions, 104 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
204% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 27
145% more call options, than puts
Call options by funds: $53M | Put options by funds: $21.6M
42% more capital invested
Capital invested by funds: $4.94B → $7.02B (+$2.08B)
18% more funds holding
Funds holding: 284 → 334 (+50)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
1.39% more ownership
Funds ownership: 96.77% → 98.16% (+1.4%)
8% more repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 104
Holders
334
Holders Change
+50
Holders Change %
+17.61%
% of All Funds
4.06%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.1%
New
82
Increased
112
Reduced
104
Closed
27
Calls
$53M
Puts
$21.6M
Net Calls
+$31.3M
Net Calls Change
+$104M
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$86.1M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$47.8M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$44.1M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$23.4M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$22.3M |
Top Sellers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$67M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$52.7M |
| 3 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$42.1M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$35.6M |
| 5 |
Millennium Management
New York
|
-$28.2M |
